News

Dan Ives on Tesla: This is a watershed moment for autonomy, more bullish after hearing Elon Musk
Dan Ives, Wedbush Securities, and Bryn Talkington, Requisite Capital, join 'Closing Bell' to discuss Elon Musk's interview ...
Cambridge Network16h
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced ...
Business Weekly17h
Shift Bioscience onboards Lord Prior and Sir Tony Kouzarides to back growth strategy
Cambridge biotech company Shift Bioscience, which is using an AI powered virtual cell to fight age-driven diseases, has ...